Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 3
2016 1
2017 1
2018 3
2020 3
2021 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action.
Willsmore ZN, Coumbe BGT, Crescioli S, Reci S, Gupta A, Harris RJ, Chenoweth A, Chauhan J, Bax HJ, McCraw A, Cheung A, Osborn G, Hoffmann RM, Nakamura M, Laddach R, Geh JLC, MacKenzie-Ross A, Healy C, Tsoka S, Spicer JF, Josephs DH, Papa S, Lacy KE, Karagiannis SN. Willsmore ZN, et al. Eur J Immunol. 2021 Mar;51(3):544-556. doi: 10.1002/eji.202048747. Epub 2021 Feb 23. Eur J Immunol. 2021. PMID: 33450785 Free article. Review.
Dynamic imaging for CAR-T-cell therapy.
Emami-Shahri N, Papa S. Emami-Shahri N, et al. Biochem Soc Trans. 2016 Apr 15;44(2):386-90. doi: 10.1042/BST20150257. Biochem Soc Trans. 2016. PMID: 27068944 Review.
COVID-19 vaccination in haematology services.
The Lancet Haematology. The Lancet Haematology. Lancet Haematol. 2021 Feb;8(2):e95. doi: 10.1016/S2352-3026(21)00003-X. Lancet Haematol. 2021. PMID: 33513376 Free PMC article. No abstract available.
Impact of age on the toxicity of immune checkpoint inhibition.
Samani A, Zhang S, Spiers L, Suwaidan AA, Merrick S, Tippu Z, Payne M, Faust G, Papa S, Fields P, Van Hemelrijck M, Josephs DH. Samani A, et al. J Immunother Cancer. 2020 Oct;8(2):e000871. doi: 10.1136/jitc-2020-000871. J Immunother Cancer. 2020. PMID: 33033183 Free PMC article.
BRAF inhibitors: resistance and the promise of combination treatments for melanoma.
Griffin M, Scotto D, Josephs DH, Mele S, Crescioli S, Bax HJ, Pellizzari G, Wynne MD, Nakamura M, Hoffmann RM, Ilieva KM, Cheung A, Spicer JF, Papa S, Lacy KE, Karagiannis SN. Griffin M, et al. Oncotarget. 2017 Aug 3;8(44):78174-78192. doi: 10.18632/oncotarget.19836. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100459 Free PMC article. Review.
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2.
Pellizzari G, Martinez O, Crescioli S, Page R, Di Meo A, Mele S, Chiaruttini G, Hoinka J, Batruch I, Prassas I, Grandits M, López-Abente J, Bugallo-Blanco E, Ward M, Bax HJ, French E, Cheung A, Lombardi S, Figini M, Lacy KE, Diamandis EP, Josephs DH, Spicer J, Papa S, Karagiannis SN. Pellizzari G, et al. J Immunother Cancer. 2021 Jun;9(6):e002140. doi: 10.1136/jitc-2020-002140. J Immunother Cancer. 2021. PMID: 34112739 Free PMC article.
16 results